Clinical Trials on Early Onset Genetic Conditions With Near Complete Penetrance in Singapore

Total 3 results

  • BioMarin Pharmaceutical
    Terminated
    A Prospective, Noninterventional, Observational Study of Late-Onset Pompe Disease
    Late-onset Pompe Patients Untreated or Treated With rhGAA
    Spain, Slovenia, Serbia, Korea, Republic of, Greece, Australia, Singapore, Brazil, Canada, Taiwan, Ireland, Poland, Romania
  • Novartis Pharmaceuticals
    Recruiting
    A Study of Safety and Efficacy of KFA115 Alone and in Combination With Pembrolizumab in Patients With Select Advanced Cancers
    Carcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung | Nasopharyngeal Carcinoma | Carcinoma, Ovarian Epithelial | Mesothelioma | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Neoplasms | Anal Cancer | Cutaneous Melanoma | Esophagogastric Cancer | Carcinoma, Thymic | High Microsatellite...
    Italy, Spain, Singapore, Germany, Taiwan, Japan, Canada, Hong Kong, United States
  • Daniel Benjamin
    Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators
    Completed
    Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care (PTN_POPS)
    Heart Failure | Epilepsy | Pain | Pneumonia | Sepsis | Inflammation | Hypertension | Chronic Kidney Diseases | Hemophilia | Schizophrenia | Central Nervous System Infections | Nosocomial Pneumonia | Insomnia | Anxiety | Bipolar Disorder | Neutropenia | Staphylococcal Infections | Bradycardia | Seizures | Urinary Tract Infections | Pulmonary... and other conditions
    United States, Canada, United Kingdom, Israel, Singapore

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe